| 000 | 01474 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513103001.0 | ||
| 264 | 0 | _c19970127 | |
| 008 | 199701s 0 0 eng d | ||
| 022 | _a0301-0430 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aConlon, P J | |
| 245 | 0 | 0 |
_aClinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis. _h[electronic resource] |
| 260 |
_bClinical nephrology _cSep 1996 |
||
| 300 |
_a170-5 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aBiopsy |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 |
_aKidney _xpathology |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xepidemiology |
| 650 | 0 | 4 |
_aLupus Nephritis _xdiagnosis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aFischer, C A | |
| 700 | 1 | _aLevesque, M C | |
| 700 | 1 | _aSmith, S R | |
| 700 | 1 | _aSt Clair, E W | |
| 700 | 1 | _aAllen, N B | |
| 700 | 1 | _aFleming, J A | |
| 700 | 1 | _aHowell, D N | |
| 773 | 0 |
_tClinical nephrology _gvol. 46 _gno. 3 _gp. 170-5 |
|
| 999 |
_c8872532 _d8872532 |
||